Metabolic Basis for Susceptibility and Resistance to Aflatoxin B₁ Hepatocarcinogenesis in Rodents

References

• Wogan G.N. Dietary Factors and Special Epidemiological Situations of Liver Cancer in Thailand and Africa. Cancer Res. 1975; 35: 3499–3502
   PubMed Web of Science ®Google Scholar
• Harris Sun C.C. Multifactorial Etiology of Human Liver Cancer. Carcinogenesis (Lond.) 1984; 5: 697–701
   PubMed Web of Science ®Google Scholar
• van Rensburg S.J., Cook-Mozaffari P., van Schalkwyk D.J., Van Der Watt J.J., Vincent T.J., Purchase I.F. Hepatocellular Carcinoma and Dietary Aflatoxin in Mozambique and Transkei. Br. J. Cancer 1985; 51: 713–726
   PubMed Web of Science ®Google Scholar
• Rajagopalan M.S., Busch M.P., Blum H.F., Vyas G.N. Interaction of Aflatoxin and Hepatitis B Virus in the Pathogenesis of Hepatocellular Carcinoma. Life Sciences 1986; 39: 1287–1290
   PubMed Web of Science ®Google Scholar
• Campbell T.C., Hayes J.R. The Role of Aflatoxin Metabolism in its Toxic Lesion. Toxicol. Appl. Pharmacol. 1976; 35: 199–222
   PubMed Web of Science ®Google Scholar
• Miller J.A., Miller E.C. Ultimate Chemical Carcinogens as Reactive Mutagenic Electrophiles. Origins of Human Cancer, H.H. Hiatt, J.D. Watson, J.A. Winsten. Cold Spring Harbor. 1977; 605–627
   Google Scholar
• Essigmann J.M., Croy R.G., Nadzan A.M., Busby W.F., Jr., Reinhold V.N., Büchi G., Wogan G.N. Structural Identification of the Major DNA Adduct Formed by Aflatoxin B1 In Vitro. Proc. Natl. Acad. Sci. USA 1977; 74: 1870–1874
   PubMed Web of Science ®Google Scholar
• Essigmann J.M., Croy R.G., Bennett R.A., Wogan G.N. Metabolic Activation of Aflatoxin B1: Patterns of DNA Adduct Formation, Removal and Excretion in Relation to Carcinogenesis. Drug Metab. Rev. 1982; 13: 581–602
   PubMed Web of Science ®Google Scholar
• Wong J.J., Hsieh D.P.H. Mutagenicity of Aflatoxins Related to their Metabolism and Carcinogenic Potential. Proc. Natl. Acad. Sci. USA 1976; 73: 2241–2244
   PubMed Web of Science ®Google Scholar
• Gurtoo H.L., Dahms R.P., Paigen B. Metabolic Activation of Aflatoxins Related to their Mutagenicity. Biochem. Biophys. Res. Commun. 1978; 81: 965–972
   PubMed Web of Science ®Google Scholar
• Lin J.K., Miller J.A., Miller E.C. 2,3-Dihydro-2(guan-7-yl)-3-hydroxy-aflatoxin B1, a Major Acid Hydrolysis Product of Aflatoxin B1-DNA or Ribosomal RNA Adducts Formed in Hepatic Microsome-Mediated Reactions and in Rat Liver In Vivo. Cancer Res. 1977; 37: 4430–4438
   PubMed Web of Science ®Google Scholar
• Degen G.H., Neumann H.G. The Major Metabolite of Aflatoxin B1 in the Rat is a Glutathione Conjugate. Chem. Biol. Interactions 1978; 22: 239–255
   PubMed Web of Science ®Google Scholar
• Moss E.J., Judah D.J., Przybylski M., Neal G.E. Some Mass Spectral and n.m.r. Analytical Studies of a Glutathione Conjugate of Aflatoxin B1. Biochem. J. 1983; 210: 227–233
   PubMed Web of Science ®Google Scholar
• Coles B., Meyer D.J., Ketterer B., Stanton C.A., Garner R. Studies on the Detoxication of Microsomally-Activated Aflatoxin B1 by Glutathione and Glutathione Transferases In Vitro. Carcinogenesis (Lond.) 1985; 6: 693–697
   PubMed Web of Science ®Google Scholar
• Newberne P.M., Butler W.H. Acute and Chronic Effects of Aflatoxin on the Liver of Domestic and Laboratory Animals: A review. Cancer Res. 1969; 29: 236–250
   PubMed Web of Science ®Google Scholar
• Herrold K.M. Aflatoxin Induced Lesions in Syrian Hamsters. Br. J. Cancer 1969; 23: 655–660
   PubMed Web of Science ®Google Scholar
• Moore M.R., Pitot H.C., Miller E.C., Miller J.A. Cholangiocellular Carcinomas Induced in Syrian Golden Hamsters Administered Aflatoxin B1 in Large Doses. J. Natl. Cancer Inst. 1982; 68: 271–278
   PubMedGoogle Scholar
• Swenson D.H., Lin J.K., Miller E.C., Miller J.A. Aflatoxin B1-2,3-oxide as a Probable Intermediate in the Covalent Binding of Aflatoxin B1 and B2 to Rat Liver DNA and Ribosomal RNA In Vivo. Cancer Res. 1977; 37: 172–181
   PubMed Web of Science ®Google Scholar
• Garner R.C., Wright C.M. Binding of [14C]aflatoxin B1 to Cellular Macromolecules in the Rat and Hamster. Chem. Biol. Interactions 1975; 11: 123–131
   Web of Science ®Google Scholar
• Lotlikar P.D., Jhee E.C., Insetta S.M., Clearfield M.S. Modulation of Microsome-Mediated Aflatoxin B1 Binding to Exogenous and Endogenous DNA by Cytosolic Glutathione S-Transferases in Rat and Hamster Livers. Carcinogenesis (Lond.) 1984; 5: 269–276
   PubMed Web of Science ®Google Scholar
• Booth S.C., Bosenberg H., Garner R.C., Hertzog P.J., Norpoth K. The Activation of Aflatoxin B1 in Liver Slices and in Bacterial Mutagenicity Assays using Livers from Different Species Including Man. Carcinogenesis (Lond.) 1981; 2: 1063–1068
   PubMed Web of Science ®Google Scholar
• Lin J.K., Kennan K.A., Miller E.C., Miller J.A. Reduced Nicotinamide Adenine Dinucleotide Phosphate-Dependent Formation of 2,3-Dihydro-2,3-dihydroxy-aflatoxin B1 by Hepatic Microsomes. Cancer Res. 1978; 38: 2424–2428
   PubMed Web of Science ®Google Scholar
• Lotlikar P.D., Insetta S.M., Lyons P.R., Jhee E.C. Inhibition of Microsome Mediated Binding of Aflatoxin B1 to DNA by Glutathione S-Transferase. Cancer Lett. 1980; 9: 143–149
   PubMed Web of Science ®Google Scholar
• Raj H.G., Clearfield M.S., Lotlikar P.D. Comparative Kinetic Studies on Aflatoxin B1-DNA Binding and Aflatoxin B1-Glutathione Conjugation with Rat and Hamster Livers In Vitro. Carcinogenesis (Lond.) 1984; 5: 879–884
   PubMed Web of Science ®Google Scholar
• Degen G.H., Neumann H.G. Differences in Aflatoxin B1-Susceptibility of Rat and Mouse are Correlated with the Capability In Vitro to Inactivate Aflatoxin B1-Epoxide. Carcinogenesis (Lond.) 1981; 2: 299–306
   PubMed Web of Science ®Google Scholar
• O'Brien K., Moss E., Judah D., Neal G. Metabolic Basis of the Species Difference to Aflatoxin B1 Induced Hepatotoxicity. Biochem. Biophys. Res. Commun. 1983; 114: 813–821
   PubMed Web of Science ®Google Scholar
• McLean A.E.M., Marshall A. Reduced Carcinogenic Effects of Aflatoxin in Rats given Phenobarbitone. Br. J. Expt. Pathol. 1971; 52: 322–329
   Web of Science ®Google Scholar
• Williams G.M., Tanaka T., Maeura Y. Dose-Related Inhibition of Aflatoxin B1 Induced-Hepatocarcinogenesis by the Phenolic Antioxidants, Butylated Hydroxyanisole and Butylated Hydroxytoluene. Carcinogenesis (Lond.) 1986; 7: 1043–1050
   PubMed Web of Science ®Google Scholar
• Cabral J.R.P., Neal G.E. The Inhibitory Effects of Ethoxyquin on the Carcinogenic Action of Aflatoxin B1 in Rats. Cancer Lett. 1983; 19: 125–132
   PubMed Web of Science ®Google Scholar
• Gurtoo H.L., Koser P.L., Bansal S.K., Fox H.W., Sharma S.D., Mulhern A.I., Pavelic Z.P. Inhibition of Aflatoxin B1-Hepatocarcinogenesis in Rats by β-Naphthoflavone. Carcinogenesis (Lond.) 1985; 6: 675–678
   PubMed Web of Science ®Google Scholar
• Kensler T.W., Egner P.A., Dolan P.M., Groopman J.D., Roebuck B.D. Mechanism of Protection Against Aflatoxin Tumorigenicity in Rats Fed 5-(2-Pyrazinyl)-4-methyl-1,2-dithiol-3-thione (Oltlpraz) and Related 1,2-Dithiol-3-thiones and 1,2-Dithiol-3-ones. Cancer Res. 1987; 47: 4271–4277
   PubMed Web of Science ®Google Scholar
• Garner R.C. Reduction in Binding of [14C] Aflatoxin B1 to Rat Liver Macromolecules by Phenobarbitone Pretreatment. Biochem. Pharmacol. 1975; 24: 1553–1556
   PubMed Web of Science ®Google Scholar
• Lotlikar P.D., Raj H.G., Bohm L.S., Ho L.L., Jhee E.C., Tsuji K., Gopalan P. A Mechanism of Inhibition of Aflatoxin B1-DNA Binding in the Liver by Phenobarbital Pretreatment of Rats. Cancer Res. 1989; 49: 951–957
   PubMed Web of Science ®Google Scholar
• Lotlikar P.D., Clearfield M.S., Jhee E.C. Effect of Butylated Hydroxyanisole on In Vivo and In Vitro Hepatic Aflatoxin B1-DNA Binding in Rats. Cancer Lett. 1984; 24: 241–250
   PubMed Web of Science ®Google Scholar
• Jhee E.C., Ho L.L., Tsuji K., Gopalan P., Lotlikar P.D. Effect of Butylated Hydroxyanisole Pretreatment on Aflatoxin B1-DNA Binding and Aflatoxin B1-Glutathione Conjugation in Isolated Hepatocytes from Rats. Cancer Res. 1989; 49: 1357–1360
   PubMed Web of Science ®Google Scholar
• Kensler T.W., Egner P.A., Trush M.A., Bueding E., Groopman J.D. Modification of Aflatoxin B1 Binding to DNA In Vivo in Rats Fed Phenolic Antioxidants, Ethoxyquin and Dithiothione. Carcinogenesis (Lond.) 1985; 6: 759–763
   PubMed Web of Science ®Google Scholar
• Monroe D.H., Holeski C.J., Eaton D.L. Effects of Single-Dose and Repeated-Dose Pretreatment with 2(3)-Tertbutyl-4-hydroxyanisole (BHA) on the Hepatobiliary Disposition and Covalent Binding to DNA of Aflatoxin B1 in the Rat. Food Chem. Toxicol. 1986; 24: 1273–1281
   PubMed Web of Science ®Google Scholar
• Kensler T.W., Egner P.A., Davidson N.E., Roebuck B.D., Pikul A., Groopman J.D. Modulation of Aflatoxin Metabolism, Aflatoxin-N7-guanine Formation and Hepatic Tumorigenesis in Rats Fed Ethoxyquin: Role of Induction of Glutathione S-Transferase. Cancer Res. 1986; 46: 3924–3931
   PubMed Web of Science ®Google Scholar
• Mandel H.G., Manson M.M., Judah D.J., Simpson J.L., Green J.A., Forrester L.M., Wolf C.R., Neal G.E. Metabolic Basis for the Protective Effect of the Antioxidant Ethoxyquin on Aflatoxin B1 Hepatocarcinogenesis in the Rat. Cancer Res. 1987; 47: 5218–5223
   PubMed Web of Science ®Google Scholar
• Fukuyama M.Y., Hsieh D.P.M. Effect of Butylated Hydroxytoluene Pretreatment on the Excretion, Tissue Distribution and DNA Binding of [14C]aflatoxin B1 in the Rat. Food Chem. Toxicol. 1985; 23: 567–573
   PubMed Web of Science ®Google Scholar
• Chang Y., Bjeldanes L.F. R-Goitrin and BHA-Induced Modulation of Aflatoxin B1 Binding to DNA and Biliary Excretion of Thiol Conjugates in Rats. Carcinogenesis (Lond.) 1987; 8: 585–590
   PubMed Web of Science ®Google Scholar
• Santhanam K., Ho L.L., Lotlikar P.D. 1989, unpublished data
   Google Scholar
• Jhee E.C., Ho L.L., Lotlikar P.D. Effect of Butylated Hydroxyanisole Pretreatment on In Vitro Hepatic Aflatoxin B1-DNA Binding and Aflatoxin B1-Glutathione Conjugation in Rats. Cancer Res. 1988; 48: 2688–2692
   PubMed Web of Science ®Google Scholar
• Wattenberg L.W. Inhibitors of Chemical Carcinogenesis. Adv. Cancer Res. 1978; 26: 197–226
   Google Scholar